AX
The market maker who is most central to the price
AX
The market maker who is most central to the price action of a specific security. The ax can be identified by studying Level II quotes and noting which market maker seems to have the greatest effect on the security’s price.
BREAKING DOWN 'Ax'
Many day traders attempt to identify the ax in a given security and trade in the same direction as the market maker as a way to increase their odds of success. Often times, there are many market makers in a given stock and it takes time to determine which of them tends to control the price action. The ax may change over time if the traders behind the movements switch market makers to throw off those analyzing their moves.
Identifying Market Makers
Market makers can be identified using short codes that appear on Level II quotes. By using these codes, traders can determine what companies are behind what trades.
Some common market makers include:
ARCA – Archipelago Trading Services Inc.
BATS – Bats Trading Inc.
NITE – Knight Capital Inc.
CDEL – Citadel Securities Inc.
In general, traders should keep an eye on how many shares the market maker shows as available, how many they actually sell, the bid-ask spreads, and how quickly the market maker permits the stock to move in either direction. These dynamics can quickly paint a picture as to what market maker tends to actually have the most influence over a security.
Market Maker Influence
Market makers have a lot of influence over securities prices, since they effectively control the flow of capital. And, the ax has the most control since it drives most of the price action in a given day. Most market makers simply post bids and offers, manage their inventory, and take advantage of low latency for arbitrage opportunities with electronic communication networks (ECNs) and dark pools, but some engage in manipulative behaviors.
For example, a hedge fund or market maker may place a huge limit buy order at a certain price level without intending to ever execute it, which could provide the illusion of support for the security. These actions could influence both the spot and futures market for that security. The same strategy can be used to create artificial selling pressure on a stock by placing a large limit sell order that’s slightly higher than the current price.
3
Rocky Mountain High Brands, Inc. (RMHB) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
HITRUST i1 Certification: The Gold Standard in Security For a world increasingly reliant on digital infrastructure, cybersecurity certification is no longer just a badge of honor; it's a cornerstone of trust. Dentistry.One nailed this down by bagging that coveted HITRUST i1 certification. When folks talk about securing data, HITRUST might as well be speaking gospel. We're...
Continue Reading
Breaking New Ground in Neuromodulation Medical tech's on a roll, and Cala Health just hopped on the fast track with their latest launch—the Cala kIQ Plus System. This bad boy is aiming to offer relief for those grappling with hand tremors, thanks to its FDA clearance and a host of new features. It's the first of its kind, combining multiple therapy modes with an...
Continue Reading
Truss Financial Group's Bold Move Against Closing Delays In real estate, time is money. Even the most casual market observer could tell you delays can slice through a deal like a hot knife through butter. That's the headache home equity borrowers face, blindsided by closing delays that sneak up on them without warning. An Industry Bottleneck Finally Addressed Enter Truss...
Continue Reading
NYSE Texas: Carving a Niche The notion of 'Y'all Street' might seem like a gimmick, but NYSE Texas is pushing a serious agenda with its newly released white paper, 'NYSE Texas and the Reshaping of U.S. Capital Markets.' This is no small feat. Texas is already housing 235 NYSE-listed companies, boasting a colossal combined worth of $4.8 trillion. With 130 of these firms...
Continue Reading
Fresh Leadership at Northern Jet Well, if you didn’t see this coming, you’ve been snoozing on the tarmac. Northern Jet, no stranger to the skies after three decades, just roped in Matthew Harris as their new CEO from October 2, 2026. They're pulling in this hotshot with more than 25 years riding the turbulence of private aviation. And listen to this: his marching...
Continue Reading
A Missed Opportunity for Community Banks It's a classic tale: community banks sleepwalking while big players snatch up low-hanging fruit right in their own backyards. According to the latest report by Cornerstone Advisors, commissioned by Teslar Software, these banks are essentially leaving $106 billion on the table when it comes to consumer lending. That's not just chump...
Continue Reading
The Urgency of Liver Cancer Awareness Death doesn’t wait, does it? When liver cancer is the villain in question, every moment becomes precious because this beast doesn’t roar until it’s too late. Here we are in 2026, staring at nearly 31,000 annual deaths in the U.S. alone. But hope flickers with a new congressional resolution aiming to slap a bright spotlight on...
Continue Reading
JiMMYBAR! Breaks New Ground in Supplements You ever notice how some companies just know how to shake things up? Take JiMMYBAR!, for instance. The moment I read they’re making moves to get their Creatine + Protein bars into Target stores nationwide, starting October 4, I thought, “That’s one way to drag creatine out from the dusty tub and onto the shelves of...
Continue Reading
The Gadget You Didn't Know You Needed Ever feel that momentary panic when your wallet seems to have vanished into thin air? ROKFORM's fresh offering, the Signal Card, tackles that heart-stopping moment head-on. They've taken the mundane act of misplacing your wallet and transformed it with their sleek, credit-card-sized tracker. This baby pairs seamlessly with Apple Find...
Continue Reading
Adams' Provocative Debut Asks Timeless Questions Sometimes life throws a philosophical curveball, and that's exactly what John C. Adams has done with his debut novel, The Third Phase. This isn't your average political yarn—it's an intricate tapestry intertwining political intrigue, deep spiritual inquiry, and hearty doses of classic philosophy. A Whirlwind Journey...
Continue Reading
Top 5 Most Recently Viewed Articles
Thermo Fisher Scientific's Q3 Performance Overview Thermo Fisher Scientific Inc. (NYSE: TMO) recently shared its financial results for the third quarter, revealing revenue of approximately $10.59 billion. While this figure is nearly unchanged compared to the previous year, it slightly fell short of the anticipated consensus of $10.64 billion. Segment Performance Analysis...
Continue Reading
Examining Retail Earnings and Consumer Sentiment This week marks a significant moment for the retail industry as key players prepare to unveil their earnings reports. The anticipation builds as we await insights from top retailers this week. Recently, the U.S. Census Bureau shared insights on retail sales, revealing mixed results. While the figures aren’t staggering,...
Continue Reading
Surge Copper Corp. Grants Equity-Based Incentives Surge Copper Corp. (TSXV: SURG) is excited to announce a significant development in its incentive program aimed at enhancing team engagement. As part of its Share Compensation Plan, the Company has awarded a substantial number of long-term equity-based incentive awards to its dedicated employees and executives. Details of...
Continue Reading
Stepan Company Welcomes New Vice President and CFO Stepan Company, a leader in the specialty and intermediate chemicals sector, proudly announces the appointment of Ruben Velasquez as their new Vice President and Chief Financial Officer. This significant move signifies Stepan's commitment to strengthening its financial leadership. Mr. Velasquez's role becomes effective...
Continue Reading
Award-Winning Leadership in Oncology In the world of oncology, it's not every day that you see a young leader make waves like Kiana Mehring from Florida Cancer Specialists & Research Institute (FCS). This lady just nabbed the 40 Under 40 in Cancer Award, shining a light on the complicated dance of payer strategies and patient care. Recognizing folks like Mehring, who’s...
Continue Reading